Condition: Suspicion of Bladder Cancer · NMIBC Surveillance · Sponsor: Nucleix Ltd.
This is a prospective, observational study to support the development of the Bladder EpiCheck kit by collecting urine samples from subjects suspected to have a bladder tumor or under NMIBC surveillance. This is a single visit study. Each subject will sign the informed consent and provide voided urine sample. Demography and, if performed, pathology information will be collected for each subject.
This description comes directly from the study's public registry record.
Limor Klein, PhD · +972-8-9161616 · limor.k@nucleix.com
Always discuss trial participation with your own doctor first.
| Om Research LLC | San Diego, California, United States | Recruiting |
| Chesapeake Urology Research Associates | Towson, Maryland, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07514143